SCYL2 Activators
SCYL2 Activators are a diverse group of chemical compounds that enhance the functional activity of SCYL2 through various signaling pathways. Forskolin and IBMX, by increasing intracellular cAMP levels, indirectly enhance SCYL2's activity through the activation of protein kinase A (PKA), which is known to phosphorylate key substrates that could be involved in SCYL2's function. PMA, as an activator of protein kinase C (PKC), could phosphorylate substrates that modulate SCYL2's activity, while epigallocatechin gallate (EGCG), as a kinase inhibitor, may reduce competitive signaling pathways, potentially leading to an increase in SCYL2 functional activity. The PI3K inhibitors LY294002 and Wortmannin could alter downstream AKT signaling, indirectly influencing SCYL2 activity by affecting signaling equilibrium. Additionally, MEK1/2 inhibitor U0126 and p38 MAPK inhibitor SB203580 could shift cellular signaling dynamics in a manner that favors the activation of SCYL2.
The influence of calcium signaling on SCYL2 activity is highlighted by A23187, a calcium ionophore that raises intracellular calcium levels, which could, in turn, activate calcium-dependent kinases and phosphatases that modulate SCYL2 function. Staurosporine, a broad-spectrum kinase inhibitor, may alter the phosphorylation state of proteins within pathways that SCYL2 is involved in, leading to its enhanced activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which in turn activates protein kinase A (PKA). PKA phosphorylates various proteins that could be involved in trafficking and cellular signaling, where SCYL2 is implicated in the coordination of such processes. Enhanced PKA activity could therefore indirectly enhance the functional activity of SCYL2 in its role in intracellular trafficking. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that could impact a range of signaling pathways including those involved in cellular metabolism and stress responses. By inhibiting certain kinases, EGCG may create a cellular environment that necessitates increased protein trafficking, potentially upregulating SCYL2 activity as a compensatory mechanism. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule is implicated in various signaling pathways, including those that regulate cytoskeletal rearrangement and trafficking. SCYL2, involved in vesicular transport, might be indirectly activated when sphingosine-1-phosphate signaling is enhanced, requiring efficient vesicular transport mechanisms. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting SCYL2 by activating calcium-dependent protein kinases and phosphatases that modulate trafficking and signaling pathways, where SCYL2 may be indirectly activated to support these processes. | ||||||